SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-227682
Filing Date
2017-07-13
Accepted
2017-07-13 17:28:02
Documents
4
Period of Report
2017-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d412155d8k.htm 8-K 20077
2 EX-1.1 d412155dex11.htm EX-1.1 207231
3 EX-5.1 d412155dex51.htm EX-5.1 14830
4 GRAPHIC g412155123.jpg GRAPHIC 13587
  Complete submission text file 0001193125-17-227682.txt   257064
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-36830 | Film No.: 17964172
SIC: 2834 Pharmaceutical Preparations